Navigation Links
Second ISPE-FDA Event Attracts Top Names, Features Release of Drug Shortage Survey Results
Date:4/16/2013

TAMPA, Fla., April 16, 2013 /PRNewswire/ -- ISPE announced today that it will hold its second annual Redefining the "C" in CGMP conference, 11 – 13 June in Baltimore, Maryland USA. Themed "Ensuring a Reliable Supply of Quality Medicines," the event will feature strategic education on issues of interest to industry leaders and global regulatory officials focused on quality systems, processes and technology utilization that drive quality enhancements that support a reliable drug supply.

"This event is where industry and regulators must come together to share their views on contemporary regulatory issues and solutions," said ISPE President and CEO Nancy Berg . "The sessions, case studies and workshops will be focused on how great companies are establishing and sustaining a culture of quality through contemporary quality management strategies, new methods and technologies, metrics and more effective approaches to integrating suppliers into quality systems."

The event will feature top speakers from the pharmaceutical industry and regulatory agencies, including:

  • Howard Sklamberg , Director, Office of Compliance, US FDA
  • Andy Skibo , Regional Vice President, Biologics-Supply, MedImmune/AstraZeneca
  • Gerald Heddell , Director of Inspection, Enforcement and Standards, MHRA, UK
  • John Pinion , Senior Vice President, Quality/Compliance, Genentech, Inc.
  • Zena Kaufman , Senior Vice President, Global Quality, Hospira
  • Cindy Salamon , Vice President, Global Quality Services, Bristol-Myers Squibb
  • Carol Bye , Vice President, Pharmaceutical Sciences Quality Operations, Pfizer, Inc.

Education content will focus on providing attendees with new insights and executable action plans to help resolve challenges related to quality leadership, quality metrics, CMO quality management, flexible manufacturing and other hot topics related to product quality and patient safety. The event will also feature the first public release of key data resulting from the ISPE Drug Shortage Survey, with an expert industry team providing commentary on the ISPE research, the impact of drug shortages and potential solutions. A Meet the Press session will feature a joint regulatory and industry panel answering questions from recognized pharma media experts on strategies for industry and regulatory collaboration, as well as compliance and product quality issues.

More information on the Redefining the "C" in CGMP Conference, including complete education details and registration information, is available at www.ISPE.org/2013CGMPConference.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Announces Second Quarter 2013 Earnings Conference Call Thursday, April 25, 2013
2. Span-America Medical Systems To Release Second Quarter Results On May 1, 2013
3. BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
4. VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
5. Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Second Quarter Earnings Conference Call and Webcast
6. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
7. Hologic to Release Second Quarter Fiscal 2013 Operating Results on Monday, May 6, 2013
8. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
9. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
10. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
11. Millennium Research Group Sponsors Case Competition at Western University for Second Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... North Carolina , 12 februari 2016 ... Inc. (AAI/CML), een toonaangevende leverancier van productie ... en biotechnologische industrieën, kondigt vandaag een uitbreiding ... mogelijkheden op haar locatie in ... vraag heeft geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Young Asset Protection, ... the beginning of the latest charity campaign in their community enrichment program. Art ... to this worthy cause are currently being accepted at: http://artexpressioninc.org/ . , ...
(Date:2/12/2016)... ... ... Miami Dental Specialists is excited to bring patients the choice of ceramic, ... Miami Dental Specialists will offer the non-metal implants as a safe, holistic and hygienic ... by the dental implant manufacturer, Straumann, to bring this cutting-edge technology to Miami. ...
(Date:2/12/2016)... ... February 12, 2016 , ... J Thomas & ... continuing it’s commitment to act as Agents of Change in the community, announces ... area homeless families to fulfill immediate needs and help them move into permanent ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... foods choices that promote eye health. These articles generally list between five and ... health advocate Sharon Kleyne endorses every one of these lists and believes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... Homeowners now have ... possibilities. CertainTeed, North America’s leading brand of building products, has improved upon its ... in the mobile version of the ColorView® Exterior Style and Color Selector. Created ...
Breaking Medicine News(10 mins):